Group President Jesse Collins Sold A Bunch Of Shares In Arcosa

We wouldn't blame Arcosa, Inc. (NYSE:ACA) shareholders if they were a little worried about the fact that Jesse Collins, the Group President recently netted about US$744k selling shares at an average price of US$86.40. That's a big disposal, and it decreased their holding size by 41%, which is notable but not too bad.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Arcosa Insider Transactions Over The Last Year

In the last twelve months, the biggest single purchase by an insider was when President Antonio Carrillo bought US$995k worth of shares at a price of US$82.27 per share. So it's clear an insider wanted to buy, at around the current price, which is US$87.00. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. While we always like to see insider buying, it's less meaningful if the purchases were made at much lower prices, as the opportunity they saw may have passed. The good news for Arcosa share holders is that insiders were buying at near the current price.

Happily, we note that in the last year insiders paid US$2.1m for 25.97k shares. But they sold 13.45k shares for US$1.2m. In the last twelve months there was more buying than selling by Arcosa insiders. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

See our latest analysis for Arcosa

There are always plenty of stocks that insiders are buying. If investing in lesser known companies is your style, you could take a look at this free list of companies. (Hint: insiders have been buying them).

Insider Ownership Of Arcosa

For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Insiders own 1.8% of Arcosa shares, worth about US$78m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

So What Do The Arcosa Insider Transactions Indicate?

Insiders sold stock recently, but they haven't been buying. On the other hand, the insider transactions over the last year are encouraging. We like that insiders own a fair amount of the company. So we're not overly bothered by recent selling. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. At Simply Wall St, we've found that Arcosa has 4 warning signs (1 doesn't sit too well with us!) that deserve your attention before going any further with your analysis.

Of course Arcosa may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.